Olfosonide (Budesonide)

Budesonide, the active ingredient in Olfosonide, is a glucocorticoid corticosteroid presented as a strength/form for oral use. It treats inflammatory conditions of the respiratory tract and gastrointestinal tract in adults and children. GNH USA supplies Olfosonide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olfosonide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Budesonide acts on inflammatory pathways in the respiratory and gastrointestinal systems.

- Asthma: helps reduce the frequency of bronchial constriction episodes. - Chronic obstructive pulmonary disease (COPD): contributes to improved lung function and symptom control. - Allergic rhinitis: alleviates nasal congestion and sneezing. - Inflammatory bowel disease (IBD): supports remission of colonic inflammation. - Eosinophilic esophagitis: reduces esophageal eosinophil counts and dysphagia. - Nasal polyps: shrinks polyp size and improves nasal airflow .

Budesonide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Oral thrush: fungal overgrowth in the mouth. - Hoarseness: voice changes due to local irritation. - Cough: transient irritation of the airway. - Headache: mild, non‑specific headache. - Nasal irritation: dryness or burning sensation. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe fungal infection: systemic candidiasis. - Glaucoma or cataract formation: increased intra‑ocular pressure. - Osteoporosis: decreased bone mineral density with long‑term use. - Hypersensitivity reactions: rash, urticaria, anaphylaxis. - Pneumonia: increased risk of lower respiratory infection.

When using Budesonide, several safety considerations should be observed.

- Monitor adrenal function: assess cortisol levels in long‑term therapy. - Evaluate infection risk: watch for signs of fungal or bacterial infections. - Use lowest effective dose: minimize systemic exposure. - Counsel on proper inhaler technique: reduce oropharyngeal deposition. - Review bone health: consider calcium/vitamin D supplementation if therapy exceeds 3 months. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Budesonide can interact with several drug classes, affecting its efficacy or safety.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors: e.g., ketoconazole, itraconazole, may increase systemic exposure. - Systemic immunosuppressants:   - Antifungal   -   Moderate  

t  """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""